European Medicines Agency - News and press release archive - Are you an SME interested in funding of Adverse Drug Reaction research through the European Commission’s 7th Framework Programme?

Are you an SME interested in funding of Adverse Drug Reaction research through the European Commission’s 7th Framework Programme?

26/07/2010 - This message is targeted at service providers with expertise in the field of pharmacovigilance, pharmacoepidemiology and health outcome research and that qualify as micro, small and medium-sized enterprises (SMEs) interested in public funding of Adverse Drug Reaction research through the 7th Framework Programme (FP7).

The European Medicines Agency and the European Commission DG Research are considering organising a joint workshop on 13 September 2010 to raise awareness on the potential funding opportunities through the 7th Framework Programme for health research in 2011 and provide guidance to interested parties on the application procedure to be followed to facilitate applications from SMEs. The workshop will be confirmed in the event of sufficient interest i.e. receipt of a considerable number of pre-registrations.

As regards the nature of the service providers, this workshop is particularly intended for but not limited to: Contract Research Organisations (CROs), service providers, academic spin-off companies, consultancies with a specific interest and work experience in the field of pharmacovigilance, pharmacoepidemiology, health outcome research, patient-reported outcomes, drug utilisation studies, etc. It is not intended for pharmaceutical companies (i.e. Marketing Authorisation Holders).

To register your interest in this initiative, please send by 15th August 2010 the following information by email to: encepp_secretariat@ema.europa.eu

Contact name
Name and address of organisation
Brief description of activities covered
Further information on future FP7 calls and specifically on the proposed priorities for adverse drug reaction research can be found in the Commission’s Orientation Paper at: ftp://ftp.cordis.europa.eu/pub/fp7/health/docs/healthres2011-orientation_en.pdf.
or the ENCePP (European Network of Centres for Pharmacoepidemiology and Pharmacovigilance) website at: http://www.encepp.eu/events/index.html


open here to see the full-text:
European Medicines Agency - News and press release archive - Are you an SME interested in funding of Adverse Drug Reaction research through the European Commission’s 7th Framework Programme?